Indication
Vascular Diseases
19 clinical trials
22 products
1 drug
Clinical trial
A Phase 3 Open-label Extension (OLE) Study to Evaluate the Long-term Safety and Efficacy of Ralinepag in Subjects With World Health Organization (WHO) Group 1 Pulmonary Arterial Hypertension (PAH)Status: , Estimated PCD: 2024-09-01
Product
RalinepagProduct
OriCAR-017Clinical trial
A Phase I/II, Open-label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of Anti-GPRC5D CAR-T Cell Product (OriCAR-017) in Subjects With Relapsed/Refractory Multiple Myeloma.Status: Recruiting, Estimated PCD: 2026-12-12
Product
Ammonia N-13Clinical trial
Ammonia N-13 Myocardial Blood Flow Absolute Quantification by Positron Emission Tomography in Patients With Known or Suspected Coronary Artery Disease (Ammonia MAP)Status: Recruiting, Estimated PCD: 2024-08-01
Product
CYNK-001Clinical trial
A Phase I Study of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK 001) in Multiple Myeloma Patients Following Autologous Stem Cell Transplant in the Front-line Setting.Status: Active (not recruiting), Estimated PCD: 2023-01-31
Product
Human Acellular VesselClinical trial
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by CPET in Subjects With WHO Group 1 Pulmonary Hypertension Who Recently Initiated TherapyStatus: Terminated, Estimated PCD: 2023-04-12
Product
PlaceboClinical trial
General Anesthesia for Endovascular Thrombectomy; A Pilot Study.Status: Completed, Estimated PCD: 2020-12-01
Product
SevofluraneProduct
LidocaineClinical trial
Pharmacovigilance Assessment of Reporting of Cardiovascular Adverse Events With Antineoplastic Agents (PARCA)Status: Not yet recruiting, Estimated PCD: 2024-06-30
Product
Antineoplastic AgentsClinical trial
Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD): A Prospective, Multicenter, Randomized, Controlled TrialStatus: Recruiting, Estimated PCD: 2025-04-30
Product
Clopidogrel + AspirinProduct
AspirinClinical trial
Tranexamic Acid Administration Strategies in Cardiovascular Surgery: Goal-directed Tranexamic Acid Administration Based on Viscoelastic Test vs. Empirical Tranexamic Acid AdministrationStatus: Recruiting, Estimated PCD: 2024-08-31
Product
TXAProduct
Placebo administrationClinical trial
11C-PIB PET Study in the Multi Ethnic Study of Atherosclerosis at Columbia UniversityStatus: , Estimated PCD: 2025-06-30
Product
11C-PIBClinical trial
A Randomized Controlled Trial to Assess the Effect of Intensive Blood Pressure Control on Major Cardiovascular Events in Stroke PatientsStatus: Active (not recruiting), Estimated PCD: 2025-12-01
Clinical trial
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAHStatus: Recruiting, Estimated PCD: 2024-12-01
Drug
VarlilumabClinical trial
The Effects of Soluble Guanylyl Cyclase Stimulation on Perioperative Vascular Reactivity and Organ Injury in Cardiac SurgeryStatus: Recruiting, Estimated PCD: 2026-10-01
Product
VericiguatClinical trial
Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant RecipientsStatus: Recruiting, Estimated PCD: 2028-10-31
Product
DapagliflozinClinical trial
Treatment With Aspirin After Preeclampsia: TAP TrialStatus: Not yet recruiting, Estimated PCD: 2025-04-01
Clinical trial
A Real-world Study on the Effectiveness and Safety of Butylphthalide in the Treatment of Ischemic Stroke.Status: Recruiting, Estimated PCD: 2025-09-01
Product
ButylphthalideClinical trial
Contribution of the Integrase Inhibitor Dolutegravir to Obesity and Cardiovascular Disease in Persons Living With HIVStatus: Completed, Estimated PCD: 2022-06-17
Product
DolutegravirProduct
AntiretroviralClinical trial
Effect of Alkali Therapy on Vascular and Graft Function in Kidney TransplantStatus: Recruiting, Estimated PCD: 2026-08-31
Product
Sodium bicarbonate